Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: A systematic review including our case series

Bioscience Reports

Volumn 33, Issue 6, 2013, Pages

  Folgueira, Maria Aparecida Azevedo Koike ^a   Maistro, Simone ^a   Katayama, Maria Lucia Hirata ^a   Roela, Rosimeire Aparecida ^a   Mundim, Fiorita Gonzales Lopes ^d   Nanogaki, Suely ^c   De Bock, Geertruida H ^b   Brentani, M Mitzi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d UNIVERSIDADE DO VALE DO SAPUCAÍ   (Brazil)

Author keywords

Breast cancer; Cancer associated fibroblasts; Caveolin 1; Lymph node metastasis; MMP13; Podoplanin

Indexed keywords

BIOLOGICAL MARKER; CAVEOLIN 1; CELL PROTEIN; COLLAGENASE 3; LECTIN GALACTOSIDE BINDING SOLUBLE 1; PODOPLANIN; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ASSOCIATED FIBROBLAST; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; DISEASE ASSOCIATION; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGIONAL METASTASIS; RETROSPECTIVE STUDY; STROMA; SYSTEMATIC REVIEW; TISSUE MICROARRAY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FIBROBLASTS; GALECTIN 1; HUMANS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 13; ODDS RATIO; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892570808     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20130060     Document Type: Article

References (52)

1. Bhowmick, N. A. and Moses, H. L. (2005) Tumor-stroma interactions. Curr. Opin. Genet. Dev. 15, 97-101
2. Hasebe, T., Sasaki, S., Imoto, S. and Ochiai, A. (2000) Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast. Am. J. Pathol. 156, 1701-1710
3. de Kruijf, E. M., van Nes, J. G., van de Velde, C. J., Putter, H., Smit, V. T., Liefers, G. J., Kuppen, P. J., Tollenaar, R. A. and Mesker, W. E. (2011) Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res. Treat. 125, 687-696
4. Ahn, S., Cho, J., Sung, J., Lee, J. E., and Nam., S. J., Kim, K. M. and Cho, E. Y. (2012) The prognostic significance of tumor-associated stroma in invasive breast carcinoma. Tumour Biol. 33, 1573-1580
5. Allen, M. and Louise Jones, J. (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 223, 162-76
6. Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A. et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 6, 17-32
7. Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A. et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518-527
8. Singer, C. F., Gschwantler-Kaulich, D., Fink-Retter, A., Haas, C., Hudelist, G., Czerwenka, K. and Kubista, E. (2008) Differential gene expression profile in breast cancer-derived stromal fibroblasts. Breast Cancer Res. Treat. 110, 273-281
9. Bauer, M., Su, G., Casper, C., He, R., Rehrauer, W. and Friedl, A. (2010) Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene 29, 1732-1740
10. Tchou, J., and Kossenkov., A. V., Chang, L., Satija, C., Herlyn, M., Showe, L. C. and Puré, E. (2012) Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles. BMC Med. Genomics 5, 39
11. Campos, L. T., Brentani, H., Roela, R. A., and Katayama., M. L., Lima, L., Rolim, C. F., Milani, C., Folgueira, M. A. and Brentani, M. M. (2013) Differences in transcriptional effects of 1α, 25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues. J. Steroid Biochem. Mol. Biol. 133, 12-24
12. Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T. and Nikolsky, Y. (2008) Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13, 394-406
13. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y. and Campisi, J. (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U.S.A. 98, 12072-12077
14. Santos, R. P., and Benvenuti., T. T., Honda, S. T., Del Valle, P. R., Katayama, M. L., Brentani, H. P., Carraro, D. M., Rozenchan, P. B., Brentani, M. M., de Lyra, E. C. et al. (2011) Influence of the interaction between nodal fibroblast and breast cancer cells on gene expression. Tumour Biol. 32, 145-157
15. Casbas-Hernandez, P., Fleming, J. M. and Troester, M. A. (2011) Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma. J. Biomed. Biotechnol. 2011, 520987
16. Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., and Gray., J. W., Carey, L., Richardson, A. and Weinberg, R. A. (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 4966-4971
17. Rozenchan, P. B., and Carraro., D. M., Brentani, H., de Carvalho Mota, L. D., Bastos, E. P., e Ferreira, E. N., Torres, C. H., Katayama, M. L., Roela, R. A., Lyra, E. C. et al. (2009) Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int. J. Cancer 125, 2767-2777
18. Planche, A., Bacac, M., Provero, P., Fusco, C., Delorenzi, M., Stehle, J. C. and Stamenkovic, I. (2011) Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. PLoS ONE 6, e18640
19. Bianchini, G., Qi, Y., Alvarez, R. H., Iwamoto, T., Coutant, C., Ibrahim, N. K., Valero, V., Cristofanilli, M., Green, M. C., Radvanyi, L. et al. (2010) Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. J. Clin. Oncol. 28, 4316-4323
20. Bergamaschi, A., Tagliabue, E., Sørlie, T., Naume, B., Triulzi, T., Orlandi, R., Russnes, H. G., and Nesland., J. M., Tammi, R., Auvinen, P. et al. (2008) Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J. Pathol. 214, 357-36
21. Rochefort, H. (1990) Biological and clinical significance of cathepsin D in breast cancer. Semin. Cancer Biol. 1, 1531-60
22. Harris, A. L., Fox, S., Bicknell, R., Leek, R., Relf, M., LeJeune, S. and Kaklamanis, L. (1994) Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. Cancer 74, 1021-1025
23. Price, J. E. (1996) Metastasis from human breast cancer cell lines. Breast Cancer Res. Treat. 39, 93-102
24. Hanada, R., Hanada, T., Sigl, V., Schramek, D. and Penninger, J. M. (2011) RANKL/RANK-beyond bones. J. Mol. Med (Berl.). 89, 647-656
25. Huang, W., Pal, A. and Kleer, C. G. (2011) On how CCN6 suppresses breast cancer growth and invasion. J. Cell Commun. Signal. 6, 5-10
26. Bierie, B. and Moses, H. L. (2009) Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 8, 3319-3327
27. de Sousa, M. (2011) An outsider's perspective-ecotaxis revisited: an integrative review of cancer environment, iron and immune system cells. Integr. Biol. 3, 343-349
28. Pula, B., Jethon, A., Piotrowska, A., Gomulkiewicz, A., Owczarek, T., Calik, J., Wojnar, A., Witkiewicz, W., Rys, J., Ugorski, M. et al. (2011) Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. Histopathology 59, 1249-1260
29. Qian, N., Ueno, T., Kawaguchi-Sakita, N., Kawashima, M., Yoshida, N., Mikami, Y., Wakasa, T., Shintaku, M., Tsuyuki, S., Inamoto, T. and Toi, M. (2011) Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients. Cancer Sci. 102, 1590-1596
30. Zhang, B., Cao, X., Liu, Y., Cao, W., Zhang, F., Zhang, S., Li, H., Ning, L., Fu, L., Niu, Y. et al. (2008) Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 8, 83
31. Dublin, E., Hanby, A., Patel, N. K., Liebman, R. and Barnes, D. (2000) Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology. Am. J. Pathol. 157, 1219-1227
32. Schoppmann, S. F., Berghoff, A., Dinhof, C., Jakesz, R., Gnant, M., Dubsky, P., Jesch, B., Heinzl, H. and Birner, P. (2012) Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Res. Treat. 134, 237-244
33. Hemsen, A., Riethdorf, L., Brünner, N., Berger, J., Ebel, S., Thomssen, C., Jänicke, F. and Pantel, K. (2003) Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells. Int. J. Cancer 107, 903-909
34. Jung, E. J., and Moon., H. G., Cho, B. I., Jeong, C. Y., and Joo., Y. T., Lee, Y. J., Hong, S. C., and Choi., S. K., Ha, W. S., Kim, J. W. et al. (2007) Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int. J. Cancer 120, 2331-2338
35. Ioachim, E., Damala, K., Tsanou, E., Briasoulis, E., Papadiotis, E., Mitselou, A., Charhanti, A., Doukas, M., Lampri, L. and Arvanitis, D. L. (2012) Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components. Histol. Histopathol. 27, 209-216
36. Nakopoulou, L., Katsarou, S., Giannopoulou, I., Alexandrou, P., Tsirmpa, I., Panayotopoulou, E., Mavrommatis, J. and Keramopoulos, A. (2002) Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer. Mod. Pathol. 15, 26-34
37. Witkiewicz, A. K., Dasgupta, A., Sotgia, F., Mercier, I., and Pestell., R. G., Sabel, M., Kleer, C. G., Brody, J. R. and Lisanti, M. P. (2009) An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am. J. Pathol. 174, 2023-2034
38. West, R. B., and Nuyten., D. S., Subramanian, S., Nielsen, T. O., and Corless., C. L., Rubin, B. P., Montgomery, K., Zhu, S., Patel, R., Hernandez-Boussard, T. et al. (2005) Determination of stromal signatures in breast carcinoma. PLoS Biol. 3, e187
39. González, L. O., Corte, M. D., Junquera, S., González- Fernańdez, R., del Casar, J. M., García, C., Andicoechea, A., Vázquez, J., Pérez-Fernańdez, R. and Vizoso, F. J. (2009) Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma. Hum. Pathol. 40, 1224-1233
40. García, M. F., González-Reyes, S., González, L. O., Junquera, S., Berdize, N., Del Casar, J. M., Medina, M. and Vizoso, F. J. (2010) Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer. Int. J. Exp. Pathol. 91, 324-334
41. Sauer, G., Schneiderhan-Marra, N., Kazmaier, C., Hutzel, K., Koretz, K., Muche, R., Kreienberg, R., Joos, T. and Deissler, H. (2008) Prediction of nodal involvement in breast cancer based on multiparametric protein analyses from preoperative core needle biopsies of the primary lesion. Clin. Cancer Res. 14, 3345-3353
42. Kim, H. J., and Park., C. I., Park, B. W., Lee, H. D. and Jung, W. H. (2006) Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. Yonsei Med. J. 47, 333-342
43. Dalotto-Moreno, T., Croci, D. O., and Cerliani., J. P., Martinez-Allo, V. C., Dergan-Dylon, S., Meńdez-Huergo, S. P., Stupirski, J. C., Mazal, D., Osinaga, E. and Toscano, M. A. (2013) Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease. Cancer Res. 73, 1107-1117
44. Fontana, A., Filleur, S., Guglielmi, J., Frappart, L., Bruno-Bossio, G., Boissier, S., Cabon, F. and Clézardin, P. (2005) Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int. J. Cancer 116, 686-691
45. Wicki, A. and Christofori, G. (2007) The potential role of podoplanin in tumour invasion. Br. J. Cancer 96, 1-5
46. Malinowsky, K., Böllner, C., Hipp, S., Berg, D., Schmitt, M. and Becker, K. F. (2010) UPA and PAI-1 analysis from fixed tissues-new perspectives for a known set of predictive markers. Curr. Med. Chem. 17, 4370-4377
47. Hildenbrand, R. and Schaaf, A. (2009) The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Int. J. Oncol. 34, 15-23
48. Jahkola, T., Toivonen, T., von Smitten, K., Virtanen, I., Wasenius, V. M. and Blomqvist, C. (1999) Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors. Br. J. Cancer 80, 167-174
49. Sloan, E. K., and Ciocca., D. R., Pouliot, N., Natoli, A., Restall, C., and Henderson., M. A., Fanelli, M. A., Cuello-Carrioń, F. D., Gago, F. E. and Anderson, R. L. (2009) Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am. J. Pathol. 174, 2035-2043
50. Niemiec, JA, Adamczyk, A, Ambicka, A, Mucha-Małecka, A. M., Wysocki, W and Ryś, J (2013) Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal fibroblasts. Appl. Immunohistochem. Mol. Morphol, February 28. [Epub ahead of print]
51. Del Casar, JM, González-Reyes, S, González, LO, González, JM, Junquera, S, Bongera, M, García, MF, Andicoechea, A, Serra, C and Vizoso, FJ. (2010) Expression of metalloproteases and their inhibitors in different histological types of breast cancer. J. Cancer Res. Clin. Oncol. 136, 811-819
52. O'Connell, JT, Sugimoto, H, Cooke, VG, MacDonald, BA, Mehta, AI, Le Bleu, VS, Dewar, R, Rocha, RM, Brentani, RR, Resnick, MB et al. (2011) VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc. Natl. Acad. Sci. U. S. A. 108, 16002-16007